We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CLGN market cap is 65.91M. The company's latest EPS is USD -0.6273 and P/E is -9.39.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 109k | 58k | 433k | 10.18M | 43k |
| Operating Income | -4.47M | -4.68M | -3.52M | 5.68M | -4.6M |
| Net Income | -4.38M | -4.4M | -3.72M | 5.76M | -4.38M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.32M | 6.14M | 15.64M | 299k | 10.96M |
| Operating Income | -7.63M | -5.6M | 65k | -17.1M | -7.51M |
| Net Income | -11.16M | -5.77M | 237k | -16.93M | -7.02M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 40.56M | 37.77M | 35.76M | 41.57M | 37.56M |
| Total Liabilities | 4.75M | 5.49M | 5.87M | 5.53M | 5.16M |
| Total Equity | 35.81M | 32.28M | 29.89M | 36.04M | 32.4M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 10.75M | 10.84M | 51.22M | 37.77M | 34.13M |
| Total Liabilities | 6.66M | 6.36M | 6.1M | 5.49M | 5.79M |
| Total Equity | 4.09M | 4.48M | 45.12M | 32.28M | 28.34M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -10.35M | -13.7M | -3.45M | -7.19M | -418k |
| Investing | 29.23M | 28.92M | -145k | -541k | -784k |
| Financing | 1.47M | 1.87M | 803k | 892k | 1.11M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -5.7M | -4.45M | 2.5M | -13.7M | -2.76M |
| Investing | -1.46M | -519k | -31.56M | 28.92M | -1.16M |
| Financing | 5.41M | 4.47M | 38.76M | 1.87M | 1.11M |
| Market Cap | 65.91M |
| Price to Earnings Ratio | -9.39 |
| Price to Sales Ratio | 6.01 |
| Price to Cash Ratio | 2.47 |
| Price to Book Ratio | 2.33 |
| Dividend Yield | - |
| Shares Outstanding | 11.19M |
| Average Volume (1 week) | 4.89k |
| Average Volume (1 Month) | 4.93k |
| 52 Week Change | -17.04% |
| 52 Week High | 8.90 |
| 52 Week Low | 4.22 |
| Spread (Intraday) | 0.61 (10.41%) |
| Company Name | CollPlant Biotechnologies Ltd |
| Address |
4 oppenheimer rehovot, center 7670104 |
| Website | https://www.collplant.com |
| Industry | real estate (6500) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
